Guggenheim Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $967K | Sell |
|
|||||
|
2025
Q1 | $838K | Sell |
|
|||||
|
2024
Q4 | $1.05M | Sell |
|
|||||
|
2024
Q3 | $1.11M | Sell |
|
|||||
|
2024
Q2 | $1.15M | Sell |
|
|||||
|
2024
Q1 | $1.25M | Buy |
|
|||||
|
2023
Q4 | $956K | Buy |
|
|||||
|
2023
Q3 | $811K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $823K | Sell |
|
|||||
|
2022
Q3 | $894K | Sell |
|
|||||
|
2022
Q2 | $795K | Sell |
|
|||||
|
2022
Q1 | $814K | Buy |
|
|||||
|
2021
Q4 | $655K | Sell |
|
|||||
|
2021
Q3 | $974K | Buy |
|
|||||
|
2021
Q2 | $749K | Buy |
|
|||||
|
2021
Q1 | $1.04M | Buy |
|
|||||
|
2020
Q4 | $436K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $235K | Sell |
|
|||||
|
2019
Q4 | $371K | Sell |
|
|||||
|
2019
Q3 | $717K | Buy |
|
|||||
|
2019
Q2 | $536K | Sell |
|
|||||
|
2019
Q1 | $427K | Sell |
|
|||||
|
2018
Q4 | $557K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $208K | Buy |
|
|||||
|
2014
Q2 | $202K | Sell |
|
|||||
|
2014
Q1 | $202K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $312K | Sell |
|
|||||
|
2013
Q2 | $325K | Buy |
|